Seragem's Master V7 Massage Device Receives FDA Approval for Multiple Therapeutic Indications
核心洞察
Seragem (搜索)'s Master V7 therapeutic massage device has secured FDA approval for four key indications including blood circulation improvement, joint pain relief, muscle pain management, and muscle relaxation.
The device features advanced spine scanning technology and intensive heat therapy up to 65 degrees Celsius, specifically designed for targeted neck and shoulder treatment.
The FDA approval marks a significant milestone for Seragem (搜索)'s international expansion strategy, following its successful certification from Korea's Ministry of Food and Drug Safety for five therapeutic applications.
Seragem (搜索) has achieved a significant regulatory milestone as its flagship therapeutic device, Master V7, receives approval from the U.S. Food and Drug Administration (FDA) for multiple therapeutic applications. The announcement, made on January 10th, validates the device's effectiveness across four distinct medical indications.
FDA-Approved Therapeutic Applications
The Master V7 has been authorized for improving blood circulation, alleviating joint and muscle pain, and promoting muscle relaxation. These approvals significantly expand the device's therapeutic potential in the U.S. healthcare market.
Advanced Technical Features
The Master V7 distinguishes itself through sophisticated technological integration, featuring a specialized cervical mode designed for targeted neck and shoulder therapy. The device's spine scan functionality provides personalized treatment by analyzing spine length and flexibility metrics. A notable feature includes precision-controlled heat therapy, capable of reaching temperatures up to 65 degrees Celsius for effective muscle tension release through targeted acupressure.
Regulatory Achievement Portfolio
Prior to the FDA approval, the device had already secured certification from the Korea Ministry of Food and Drug Safety (搜索) for five therapeutic applications, including:
- Treatment support for intervertebral disc exodus
- Management of degenerative stenosis
- Muscle pain relief
- Blood circulation improvement
- Menstrual pain management
Market Expansion and Future Outlook
The FDA approval represents a crucial step in Seragem (搜索)'s international market strategy, opening doors for significant growth in the U.S. healthcare sector. The company recently showcased its commitment to innovation at CES 2025 in Las Vegas, where it presented its vision of a "house of the future for a healthy life" alongside its portfolio of spinal care medical devices and therapeutic massage solutions.
The expansion into the U.S. market with FDA-approved therapeutic devices positions Seragem (搜索) to address growing demand for non-pharmacological pain management and therapeutic solutions in one of the world's largest healthcare markets.